AstraZeneca CEO gets two cheers after first year in job

LONDON (Reuters)—Fixing ailing drug maker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the job. Yet confidence is slowly building that he may ...